News
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Telix Pharmaceuticals.
RELATED STOCKHEAD STORIES
Health & Biotech
ASX health stocks: Proteomics jumps 10% on blood test deal with Nasdaq-listed Abcam
News
Here are the Top 25 ASX large cap movers for Tuesday
Health & Biotech
ASX health stocks: AusCann (ASX:AC8) up 5pc after asking for approval of cannabis-based canine drug
Health & Biotech
ScoPo’s Powerplays: ‘Go long equities’ as Nanosonics, Antisense, Volpara to benefit from V-shaped recovery
Health & Biotech
The surge and plunge in ASX biotech shows what the FDA giveth, the FDA taketh away
Health & Biotech
ScoPo’s Powerplays: Buying opportunities in a volatile week
Health & Biotech
ScoPo’s Powerplays: ‘Prepare for a big jump in July’ as tax-loss selling in healthcare continues
News
Market highlights and 5 ASX small caps to watch on Monday
Health & Biotech
Why Advanced Human and other ASX imaging stocks have more than doubled in 12 months
Health & Biotech
These ASX biotechs are on the verge of releasing Phase III clinical trial results
News
Market highlights and 6 ASX small caps to watch on Thursday
News
Market highlights and 5 ASX small caps to watch on Wednesday
Health & Biotech
HealthKick Podcast: Dr Chris Behrenbruch on taking Telix Pharma to $1bn and the future of nuclear medicine
Health & Biotech
Clinical Trials Tracker: 2022 and beyond
News
Last Orders: Small caps hit another 12-year high ahead of holiday
News
ScoPo’s powerplays: Morgans’ healthcare picks for 2021
Health & Biotech